Gemcitabine plus Cisplatin in Adjuvant Regimen for Bladder Cancer

Publisher： Karger

E-ISSN： 1423-0399|71|1|37-40

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.71, Iss.1, 2003-07, pp. : 37-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer

By  

Oncology, Vol. 93, Iss. 1, 2017-04 ,pp. : 36-42

Karger

Access to resources Recommend Favorite

The Efficacy and Toxicity of Adjuvant Gemcitabine-Cisplatin Chemotherapy in Patients with Advanced Bladder Cancer Underwent Radical Cystectomy

By  

Current Urology, Vol. 4, Iss. 1, 2010-01 ,pp. : 25-29

Karger

Access to resources Recommend Favorite

Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle‐invasive bladder cancer

By  

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2586-2593

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 391-398

Karger

Access to resources Recommend Favorite

Efficacy of Adjuvant Gemcitabine-Cisplatin Chemotherapy: A Comparative Study between Locally Advanced Transitional Cell Carcinoma of the Bladder and Upper Urinary Tract

By  

Urologia Internationalis, Vol. 85, Iss. 1, 2010-03 ,pp. : 47-51

Karger

Access to resources Recommend Favorite